Soleno Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $94,603 | $91,730 | $66,018 | $32,657 |
Gross Profit | 93,405 | 90,867 | 64,876 | 31,961 |
EBITDA | 32,276 | 45,216 | 27,905 | -2,830 |
EBIT | 31,762 | 44,707 | 27,403 | -3,332 |
Net Income | 31,378 | 43,358 | 26,013 | -4,708 |
Net Change In Cash | 94,603 | 91,730 | 66,018 | 32,657 |
Free Cash Flow | 25,940 | 48,646 | 43,631 | -12,617 |
Cash | 133,026 | 70,106 | 246,662 | 76,497 |
Basic Shares | 53,066 | 54,331 | 54,921 | 50,483 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $190,405 | $0 | $0 | $0 |
Gross Profit | 187,705 | -1,987 | -1,958 | -2,210 |
EBITDA | 28,383 | -173,632 | -37,030 | -22,103 |
EBIT | 26,366 | -175,619 | -38,988 | -24,067 |
Net Income | 20,890 | -175,850 | -38,988 | -24,067 |
Net Change In Cash | 190,405 | 0 | 0 | 0 |
Free Cash Flow | 46,725 | -69,314 | -24,940 | -20,794 |
Cash | 70,106 | 87,928 | 169,681 | 14,602 |
Basic Shares | 54,331 | 40,175 | 16,492 | 8,397 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0.59 |
2025-12-31 | $0.80 |
2025-09-30 | $0.47 |
2025-06-30 | -$0.09 |